DMIIU|Drugs Made In America Acquisition II Units|Price:10.060|

More Details of Company

Drugs Made In America Acquisition II Units Info



Ticker Symbol- -

Company name- -

IPO date- -

CEO- -

Number of employees- -

Security type- -

Fiscal year-end- -

Address- -

City- -

Stock exchange- -

Country- -

Postal code- -

Phone- -

Website- -

Ticker Symbol- -

IPO date- -

CEO- -

Company Executives of Drugs Made In America Acquisition II Units



Name

Name/Position

Position

Shareholding

Change

Ms. Lynn Stockwell

Executive Chairman of the Board, Chief Executive Officer

--

Mr. Glenn Worman

Chief Financial Officer, Principal Financial and Accounting Officer

--

Dr. Catherine Do

Independent Director

--

Dr. G. Sridhar Prasad

Independent Director

--

Mr. Myron W. Shulgan

Independent Director

--

Mr. Saleem Elmasri, CPA

Chief Financial Officer, Principal Financial and Accounting Officer

--

Name

Name/Position

Position

Shareholding

Change

Ms. Lynn Stockwell

Executive Chairman of the Board, Chief Executive Officer

--

Mr. Glenn Worman

Chief Financial Officer, Principal Financial and Accounting Officer

--

Dr. Catherine Do

Independent Director

--

Dr. G. Sridhar Prasad

Independent Director

--

Mr. Myron W. Shulgan

Independent Director

--

Mr. Saleem Elmasri, CPA

Chief Financial Officer, Principal Financial and Accounting Officer

--

Revenue Breakdown

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

By Business

By Region

Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Wed, Mar 18

Shareholders

Shareholder Types

Shareholders

Proportion

MMCAP Asset Management

4.12%

LMR Partners LLP

3.05%

Healthcare Of Ontario Pension Plan

3.05%

Drugs Made In America Acquisition II LLC

1.07%

Heights Capital Management, Inc.

0.79%

Other

87.92%

Shareholders

Proportion

MMCAP Asset Management

4.12%

LMR Partners LLP

3.05%

Healthcare Of Ontario Pension Plan

3.05%

Drugs Made In America Acquisition II LLC

1.07%

Heights Capital Management, Inc.

0.79%

Other

87.92%

Shareholder Types

Shareholders

Proportion

Hedge Fund

9.74%

Investment Advisor/Hedge Fund

3.30%

Pension Fund

3.05%

Investment Advisor

1.79%

Corporation

1.07%

Other

81.06%

Institutional Shareholding



Updated: Wed, Apr 1

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2026Q1

86

11.72M

17.88%

-34.69M

2025Q4

78

46.21M

0.02%

--

2025Q3

76

45.95M

70.07%

+45.95M

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

MMCAP Asset Management

2.70M

4.12%

--

Dec 31, 2025

LMR Partners LLP

2.00M

3.05%

--

Dec 31, 2025

Healthcare Of Ontario Pension Plan

2.00M

3.05%

--

Dec 31, 2025

Drugs Made In America Acquisition II LLC

700.00K

1.07%

+700.00K

--

Oct 01, 2025

Heights Capital Management, Inc.

519.40K

0.79%

--

Dec 31, 2025

Westchester Capital Management, LLC

502.91K

0.77%

+302.91K

+151.46%

Dec 31, 2025

TIG Advisors, L.L.C.

500.00K

0.76%

--

Dec 31, 2025

Millennium Management LLC

500.00K

0.76%

-1.50M

-75.00%

Dec 31, 2025

RiverNorth Capital Management LLC

400.00K

0.61%

--

Dec 31, 2025

Gabelli Funds, LLC

340.90K

0.52%

+48.70K

+16.67%

Dec 31, 2025

Related ETFs



Updated: Tue, Dec 9

Name

Proportion

SPAC and New Issue ETF

0%

SPAC and New Issue ETF

Proportion0%

Dividend



A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Splits



Date

Ex-dividend Date

Type

Ratio

No Data

Date

Ex-dividend Date

Type

Ratio

No Data